Radionuclide Drug Conjugates Market – Advancing Targeted Radiopharmaceutical Treatment
The Radionuclide Drug Conjugates (RDC) Market focuses on therapeutic and diagnostic approaches that combine targeting molecules with radioactive isotopes. These agents are being investigated and developed to deliver radiation to specific biological targets, particularly in oncology, while supporting more targeted approaches to disease management.
Current Market Landscape
Interest in RDCs is...
Arabic
French
Spanish
Portuguese
Deutsch
Turkish
Dutch
Italiano
Russian
Romaian
Portuguese (Brazil)
Greek